Nature Communications (Jul 2023)

Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England

  • Pablo N. Perez-Guzman,
  • Edward Knock,
  • Natsuko Imai,
  • Thomas Rawson,
  • Yasin Elmaci,
  • Joana Alcada,
  • Lilith K. Whittles,
  • Divya Thekke Kanapram,
  • Raphael Sonabend,
  • Katy A. M. Gaythorpe,
  • Wes Hinsley,
  • Richard G. FitzJohn,
  • Erik Volz,
  • Robert Verity,
  • Neil M. Ferguson,
  • Anne Cori,
  • Marc Baguelin

DOI
https://doi.org/10.1038/s41467-023-39661-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 9

Abstract

Read online

Abstract As the SARS-CoV-2 pandemic progressed, distinct variants emerged and dominated in England. These variants, Wildtype, Alpha, Delta, and Omicron were characterized by variations in transmissibility and severity. We used a robust mathematical model and Bayesian inference framework to analyse epidemiological surveillance data from England. We quantified the impact of non-pharmaceutical interventions (NPIs), therapeutics, and vaccination on virus transmission and severity. Each successive variant had a higher intrinsic transmissibility. Omicron (BA.1) had the highest basic reproduction number at 8.4 (95% credible interval (CrI) 7.8-9.1). Varying levels of NPIs were crucial in controlling virus transmission until population immunity accumulated. Immune escape properties of Omicron decreased effective levels of immunity in the population by a third. Furthermore, in contrast to previous studies, we found Alpha had the highest basic infection fatality ratio (3.0%, 95% CrI 2.8-3.2), followed by Delta (2.1%, 95% CrI 1.9–2.4), Wildtype (1.2%, 95% CrI 1.1–1.2), and Omicron (0.7%, 95% CrI 0.6-0.8). Our findings highlight the importance of continued surveillance. Long-term strategies for monitoring and maintaining effective immunity against SARS-CoV-2 are critical to inform the role of NPIs to effectively manage future variants with potentially higher intrinsic transmissibility and severe outcomes.